FDA Panel Says Pfizer’s RSV Vaccine Is Safe and Effective

  • Order Reprints
  • Print Article

The Food and Drug Administration’s vaccines advisory committee on Tuesday said Pfizer ‘s data showed that its respiratory syncytial virus is safe and effective for older adults.

The vote passed narrowly, however, and the advisers raised concerns that the agency’s staff will need to contend with as they decide whether to approve the vaccine.